vs
FUELCELL ENERGY INC（FCEL）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
FUELCELL ENERGY INC的季度营收约是REGENXBIO Inc.的1.8倍（$55.0M vs $30.3M），FUELCELL ENERGY INC净利率更高（-54.3% vs -221.3%，领先167.1%），REGENXBIO Inc.同比增速更快（43.0% vs 11.5%），FUELCELL ENERGY INC自由现金流更多（$-23.9M vs $-52.8M），过去两年FUELCELL ENERGY INC的营收复合增速更高（81.6% vs 39.4%）
燃料电池能源公司是一家上市燃料电池企业，总部位于美国康涅狄格州丹伯里，公司主打基于熔融碳酸盐燃料电池技术的发电站业务，从事相关产品的设计、生产，同时还提供发电站运营及相关技术服务。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
FCEL vs RGNX — 直观对比
营收规模更大
FCEL
是对方的1.8倍
$30.3M
营收增速更快
RGNX
高出31.5%
11.5%
净利率更高
FCEL
高出167.1%
-221.3%
自由现金流更多
FCEL
多$28.9M
$-52.8M
两年增速更快
FCEL
近两年复合增速
39.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.0M | $30.3M |
| 净利润 | $-29.9M | $-67.1M |
| 毛利率 | -12.1% | — |
| 营业利润率 | -51.5% | -190.0% |
| 净利率 | -54.3% | -221.3% |
| 营收同比 | 11.5% | 43.0% |
| 净利润同比 | 27.9% | -31.2% |
| 每股收益（稀释后） | $-0.43 | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCELRGNX
| Q4 25 | $55.0M | $30.3M | ||
| Q3 25 | $46.7M | $29.7M | ||
| Q2 25 | $37.4M | $21.4M | ||
| Q1 25 | $19.0M | $89.0M | ||
| Q4 24 | $49.3M | $21.2M | ||
| Q3 24 | $23.7M | $24.2M | ||
| Q2 24 | $22.4M | $22.3M | ||
| Q1 24 | $16.7M | $15.6M |
净利润FCELRGNX
| Q4 25 | $-29.9M | $-67.1M | ||
| Q3 25 | $-91.7M | $-61.9M | ||
| Q2 25 | $-38.0M | $-70.9M | ||
| Q1 25 | $-28.3M | $6.1M | ||
| Q4 24 | $-41.4M | $-51.2M | ||
| Q3 24 | $-32.7M | $-59.6M | ||
| Q2 24 | $-32.1M | $-53.0M | ||
| Q1 24 | $-19.8M | $-63.3M |
毛利率FCELRGNX
| Q4 25 | -12.1% | — | ||
| Q3 25 | -11.0% | — | ||
| Q2 25 | -25.2% | — | ||
| Q1 25 | -27.4% | — | ||
| Q4 24 | -22.1% | 70.2% | ||
| Q3 24 | -26.2% | 48.8% | ||
| Q2 24 | -31.6% | 52.5% | ||
| Q1 24 | -70.2% | 72.6% |
营业利润率FCELRGNX
| Q4 25 | -51.5% | -190.0% | ||
| Q3 25 | -204.0% | -176.3% | ||
| Q2 25 | -95.7% | -296.3% | ||
| Q1 25 | -172.9% | 13.6% | ||
| Q4 24 | -83.2% | -242.1% | ||
| Q3 24 | -141.9% | -256.6% | ||
| Q2 24 | -184.5% | -251.3% | ||
| Q1 24 | -254.5% | -408.8% |
净利率FCELRGNX
| Q4 25 | -54.3% | -221.3% | ||
| Q3 25 | -196.1% | -208.3% | ||
| Q2 25 | -101.7% | -331.8% | ||
| Q1 25 | -149.1% | 6.8% | ||
| Q4 24 | -84.0% | -241.3% | ||
| Q3 24 | -137.8% | -246.3% | ||
| Q2 24 | -143.4% | -237.7% | ||
| Q1 24 | -118.6% | -405.4% |
每股收益（稀释后）FCELRGNX
| Q4 25 | $-0.43 | $-1.30 | ||
| Q3 25 | $-3.78 | $-1.20 | ||
| Q2 25 | $-1.79 | $-1.38 | ||
| Q1 25 | $-1.42 | $0.12 | ||
| Q4 24 | $-2.29 | $-0.99 | ||
| Q3 24 | $-1.99 | $-1.17 | ||
| Q2 24 | $-2.18 | $-1.05 | ||
| Q1 24 | $-1.37 | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $278.1M | $230.1M |
| 总债务越低越好 | $103.8M | — |
| 股东权益账面价值 | $662.2M | $102.7M |
| 总资产 | $932.1M | $453.0M |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势，按日历期对齐
现金及短期投资FCELRGNX
| Q4 25 | $278.1M | $230.1M | ||
| Q3 25 | $174.7M | $274.2M | ||
| Q2 25 | $177.0M | $323.3M | ||
| Q1 25 | $208.4M | $267.9M | ||
| Q4 24 | $257.3M | $234.7M | ||
| Q3 24 | $267.2M | $255.5M | ||
| Q2 24 | $260.1M | $290.4M | ||
| Q1 24 | $297.5M | $338.7M |
总债务FCELRGNX
| Q4 25 | $103.8M | — | ||
| Q3 25 | $106.4M | — | ||
| Q2 25 | $109.4M | — | ||
| Q1 25 | $112.3M | — | ||
| Q4 24 | $115.7M | — | ||
| Q3 24 | $112.7M | — | ||
| Q2 24 | $116.2M | — | ||
| Q1 24 | $107.2M | — |
股东权益FCELRGNX
| Q4 25 | $662.2M | $102.7M | ||
| Q3 25 | $556.2M | $161.5M | ||
| Q2 25 | $609.2M | $213.7M | ||
| Q1 25 | $635.2M | $274.2M | ||
| Q4 24 | $656.9M | $259.7M | ||
| Q3 24 | $675.8M | $301.4M | ||
| Q2 24 | $639.8M | $348.3M | ||
| Q1 24 | $663.9M | $390.7M |
总资产FCELRGNX
| Q4 25 | $932.1M | $453.0M | ||
| Q3 25 | $830.5M | $525.2M | ||
| Q2 25 | $883.8M | $581.0M | ||
| Q1 25 | $907.5M | $490.9M | ||
| Q4 24 | $944.1M | $466.0M | ||
| Q3 24 | $948.9M | $519.1M | ||
| Q2 24 | $916.8M | $569.4M | ||
| Q1 24 | $923.2M | $629.2M |
负债/权益比FCELRGNX
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.18× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.9M | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.9M | $-52.8M |
| 自由现金流率自由现金流/营收 | -43.4% | -174.0% |
| 资本支出强度资本支出/营收 | 1.8% | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-143.9M | $-126.4M |
8季度趋势，按日历期对齐
经营现金流FCELRGNX
| Q4 25 | $-22.9M | $-52.3M | ||
| Q3 25 | $-26.8M | $-56.0M | ||
| Q2 25 | $-29.9M | $-49.3M | ||
| Q1 25 | $-45.7M | $33.6M | ||
| Q4 24 | $5.8M | $-31.6M | ||
| Q3 24 | $-63.4M | $-40.5M | ||
| Q2 24 | $-37.1M | $-45.5M | ||
| Q1 24 | $-58.3M | $-55.5M |
自由现金流FCELRGNX
| Q4 25 | $-23.9M | $-52.8M | ||
| Q3 25 | $-32.1M | $-56.5M | ||
| Q2 25 | $-35.2M | $-49.7M | ||
| Q1 25 | $-52.8M | $32.6M | ||
| Q4 24 | $-4.7M | $-32.7M | ||
| Q3 24 | $-76.8M | $-40.9M | ||
| Q2 24 | $-50.3M | $-46.0M | ||
| Q1 24 | $-68.8M | $-56.0M |
自由现金流率FCELRGNX
| Q4 25 | -43.4% | -174.0% | ||
| Q3 25 | -68.6% | -189.9% | ||
| Q2 25 | -94.0% | -232.8% | ||
| Q1 25 | -277.8% | 36.6% | ||
| Q4 24 | -9.5% | -154.2% | ||
| Q3 24 | -324.0% | -168.9% | ||
| Q2 24 | -224.5% | -206.2% | ||
| Q1 24 | -412.4% | -358.5% |
资本支出强度FCELRGNX
| Q4 25 | 1.8% | 1.7% | ||
| Q3 25 | 11.2% | 1.7% | ||
| Q2 25 | 14.1% | 1.8% | ||
| Q1 25 | 37.2% | 1.2% | ||
| Q4 24 | 21.4% | 5.1% | ||
| Q3 24 | 56.6% | 1.3% | ||
| Q2 24 | 58.9% | 2.1% | ||
| Q1 24 | 63.3% | 3.6% |
现金转化率FCELRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCEL
| Other | $30.0M | 55% |
| Electricity Generation | $12.2M | 22% |
| Services | $7.3M | 13% |
| Advanced Technologies | $5.5M | 10% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
